Correlation Between EnGene Holdings and Barclays Capital

Can any of the company-specific risk be diversified away by investing in both EnGene Holdings and Barclays Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EnGene Holdings and Barclays Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between enGene Holdings Common and Barclays Capital, you can compare the effects of market volatilities on EnGene Holdings and Barclays Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EnGene Holdings with a short position of Barclays Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of EnGene Holdings and Barclays Capital.

Diversification Opportunities for EnGene Holdings and Barclays Capital

0.51

Correlation Coefficient

EnGene Holdings  Barclays Capital

Very weak diversification

The 3 months correlation between EnGene and Barclays is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding enGene Holdings Common and Barclays Capital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Barclays Capital and EnGene Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on enGene Holdings Common are associated (or correlated) with Barclays Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Barclays Capital has no effect on the direction of EnGene Holdings i.e., EnGene Holdings and Barclays Capital go up and down completely randomly.

Pair Corralation between EnGene Holdings and Barclays Capital

Given the investment horizon of 90 days enGene Holdings Common is expected to generate 4.08 times more return on investment than Barclays Capital. However, EnGene Holdings is 4.08 times more volatile than Barclays Capital. It trades about 0.03 of its potential returns per unit of risk. Barclays Capital is currently generating about -0.17 per unit of risk. If you would invest  1,033  in enGene Holdings Common on September 20, 2024 and sell it today you would lose (388.00) from holding enGene Holdings Common or give up 37.56% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	6.85%
Values	Daily Returns

enGene Holdings Common  vs.  Barclays Capital

enGene Holdings Common

Risk-Adjusted Performance

1 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in enGene Holdings Common are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, EnGene Holdings may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Barclays Capital

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Barclays Capital has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Barclays Capital is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with EnGene Holdings and Barclays Capital

The main advantage of trading using opposite EnGene Holdings and Barclays Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EnGene Holdings position performs unexpectedly, Barclays Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Barclays Capital will offset losses from the drop in Barclays Capital's long position.

The idea behind enGene Holdings Common and Barclays Capital pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.